Cargando…

Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases

BACKGROUND: To investigate the clinical relevance of two different preservative formulations, we compared 1-year incidence rates of additional coding of dry eye, ocular infection, or ocular surface disease (either dry eye or ocular infection) in open-angle glaucoma and ocular hypertension patients n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwartz, Gail F, Kotak, Sameer, Mardekian, Jack, Fain, Joel M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146461/ https://www.ncbi.nlm.nih.gov/pubmed/21672240 http://dx.doi.org/10.1186/1471-2415-11-14

Ejemplares similares

Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
por: Reardon, Gregory, et al.
Publicado: (2010)

A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy
por: Fain, Joel M, et al.
Publicado: (2011)

Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
por: Horsley, Michael B, et al.
Publicado: (2009)

Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review
por: Reardon, Gregory, et al.
Publicado: (2011)

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
por: Topouzis, Fotis, et al.
Publicado: (2019)

Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma
por: Tomić, Martina, et al.
Publicado: (2013)

Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
por: Niwano, Yoshimi, et al.
Publicado: (2014)

Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
por: Takagi, Yasutaka, et al.
Publicado: (2018)

Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
por: Tang, Wenquan, et al.
Publicado: (2019)

Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
por: Hu, Jason, et al.
Publicado: (2020)

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
por: Frenkel, Ronald EP, et al.
Publicado: (2007)

Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs
por: Lee, Susan S., et al.
Publicado: (2019)

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Eyawo, Oghenowede, et al.
Publicado: (2009)

Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
por: Tamçelik, Nevbahar, et al.
Publicado: (2017)

Travoprost in the management of open-angle glaucoma and ocular hypertension
por: Denis, Philippe, et al.
Publicado: (2007)

New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
por: Alviset, Gabriel, et al.
Publicado: (2022)

Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
por: Tirpack, Aubrey R, et al.
Publicado: (2019)

In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
por: Kim, Jee Hyun, et al.
Publicado: (2015)

Prostaglandin analogues in angle closure glaucoma
por: Gupta, Pulkit, et al.
Publicado: (2011)

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
por: Lee, Anne J, et al.
Publicado: (2010)

Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity
por: Buys, Yvonne M., et al.
Publicado: (2012)

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
por: Schultz, Clyde
Publicado: (2011)

Ocular Biometry in Primary Angle-Closure Glaucoma Associated with Retinitis Pigmentosa
por: Xu, Jiangang, et al.
Publicado: (2017)

The ocular biometry characteristics of young patients with primary angle-closure glaucoma
por: Xu, Yi, et al.
Publicado: (2022)

Ocular Biomechanics and Glaucoma
por: Brazuna, Rodrigo, et al.
Publicado: (2023)

Seasonal variation of intra-ocular pressure in glaucoma with and without dry eye
por: Kuze, Manami, et al.
Publicado: (2020)

Comparison of ocular response analyzer parameters in primary open angle glaucoma and exfoliative glaucoma patients
por: Beyazyıldız, Emrullah, et al.
Publicado: (2014)

Comparison of Ocular Biomery in Primary Open Angle Glaucoma and Non-glaucoma in South West Nigeria
por: Oluwaniyi, Ajibola Toyin, et al.
Publicado: (2023)

Ocular perfusion pressure and ocular blood flow in glaucoma
por: Cherecheanu, A Popa, et al.
Publicado: (2013)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano, Tadashi, et al.
Publicado: (2016)

Ocular decompression retinopathy after trabeculectomy with mitomycin-C for angle recession glaucoma
por: Bansal, Atul, et al.
Publicado: (2009)

Effect of trabeculectomy on ocular higher-order aberrations in patients with open angle glaucoma
por: Fard, Ali Mahdavi, et al.
Publicado: (2018)

Changes in ocular morphology after cataract surgery in open angle glaucoma patients
por: Pakuliene, Giedre, et al.
Publicado: (2021)

Choroidal Thickness and its Correlations with Ocular Parameters in Primary Open-angle Glaucoma
por: Kutluksaman, Bunyamin, et al.
Publicado: (2019)

Ocular Dominance in Open-angle Glaucoma: The Shifting Trend Depending on Stage of the Disease
por: Choi, Moon Young, et al.
Publicado: (2022)

The inflammatory cytokine profiles and ocular biometric characteristics of primary angle-closure glaucoma
por: Zeng, Hong-Bo, et al.
Publicado: (2023)

Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
por: Sharma, Sourabh, et al.
Publicado: (2015)

Comment on Comparison of ocular response analyzer parameters in primary open angle glaucoma and exfoliative glaucoma patients
por: Gundogan, Fatih C, et al.
Publicado: (2015)

Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
por: Mancino, R, et al.
Publicado: (2018)

Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier, Jordana K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_70e0p0pekburpjuh4vpj55qlh6